AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Plasmid borne genes encoding modifying enzymes such as beta-lactamases, that confer resistance to penicillins and related antibiotics, or, more recently, phosphoethanolamine transferases, that confer ...

But now, bacterial resistance against carbapenems is also on the rise. Researchers at the University of Bristol in the U.K. have applied an in silico method to model how carbapenems interact with ...

As a Ph.D. candidate, David is investigating the role of epistasis on CTX-M-14 beta-lactamase catalysis and substrate specificity using a variety of methods including DNA sequencing, enzyme kinetics ...

Synthetic biologists have developed a prototype for an innovative biosensor that can detect rare earth elements and be modified for a range of other applications.

add a new application for phage display—the design of molecular sensors based on the modulation of enzyme activity by ... close to the active site of β-lactamase and selected variants that ...

The researchers used CARBonAra to design new variants of the TEM-1 β-lactamase enzyme, which is involved in the development of antimicrobial resistance. Some of the predicted sequences ...

Australian synthetic biologists have developed a prototype for an innovative biosensor that can detect rare earth elements and be modified for a range of other applications.

that may inactivate certain beta-lactamase enzymes. Take with meals. Base dose on amoxicillin component. Due to clavulanic acid component: two 250mg tabs are not equivalent to one 500mg tab.

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

that may inactivate certain beta-lactamase enzymes. <3months: not recommended. Take with food. Base dose on amoxicillin component. Due to clavulanic acid component, ES-600 is not interchangable ...